{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Uruma Y"],"funding":["Japan Science and Technology Agency","Japan Society for the Promotion of Science"],"pagination":["e0276774"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9624422"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["17(11)"],"pubmed_abstract":["<h4>Introduction</h4>The prevalence of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO) in patients with COVID-19 varies, as well as their risks of mortality. The present study aimed to assess the prevalence of asthma, COPD, and ACO as comorbidities, and to determine their risks of mortality in patients with COVID-19 using a systematic review and meta-analysis.<h4>Methods</h4>We systematically reviewed clinical studies that reported the comorbidities of asthma, COPD, and ACO in patients with COVID-19. We searched various databases including PubMed (from inception to 27 September 2021) for eligible studies written in English. A meta-analysis was performed using the random-effect model for measuring the prevalence of asthma, COPD, and ACO as comorbidities, "],"journal":["PloS one"],"pubmed_title":["Effect of asthma, COPD, and ACO on COVID-19: A systematic review and meta-analysis."],"pmcid":["PMC9624422"],"funding_grant_id":["20345310","20KK0218"],"pubmed_authors":["Fujikura Y","Hojo M","Iikura M","Uruma Y","Kudo K","Manabe T"],"additional_accession":[]},"is_claimable":false,"name":"Effect of asthma, COPD, and ACO on COVID-19: A systematic review and meta-analysis.","description":"<h4>Introduction</h4>The prevalence of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO) in patients with COVID-19 varies, as well as their risks of mortality. The present study aimed to assess the prevalence of asthma, COPD, and ACO as comorbidities, and to determine their risks of mortality in patients with COVID-19 using a systematic review and meta-analysis.<h4>Methods</h4>We systematically reviewed clinical studies that reported the comorbidities of asthma, COPD, and ACO in patients with COVID-19. We searched various databases including PubMed (from inception to 27 September 2021) for eligible studies written in English. A meta-analysis was performed using the random-effect model for measuring the prevalence of asthma, COPD, and ACO as comorbidities, ","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-19T02:37:01.908Z","creation":"2025-04-07T13:01:25.323Z"},"accession":"S-EPMC9624422","cross_references":{"pubmed":["36318528"],"doi":["10.1371/journal.pone.0276774"]}}